Abstract
No public abstract is available from the verified source records.
Diego Loggia, Giada Castagnola, Terence E. Hébert
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cardiac GPCRs: GPCR signaling in healthy and failing hearts
10.1016/j.bbamem.2007.02.010 · 2007
G-Protein–Coupled Receptors in Heart Disease
10.1161/circresaha.118.311403 · 2018
G Protein-Coupled Receptors: A Century of Research and Discovery
10.1161/circresaha.124.323067 · 2024
Structure Modeling of All Identified G Protein–Coupled Receptors in the Human Genome
10.1371/journal.pcbi.0020013 · 2006
G protein-coupled receptor signaling: transducers and effectors
2022
Diversity of the Gβγ complexes defines spatial and temporal bias of GPCR signaling
10.1016/j.cels.2021.02.001 · 2021
The role of Gβγ subunits in the organization, assembly, and function of GPCR signaling complexes
10.1146/annurev-pharmtox-061008-103038 · 2009
G protein γ subunit, a hidden master regulator of GPCR signaling
10.1016/j.jbc.2022.102618 · 2022
The expanding roles of Gβγ subunits in G protein-coupled receptor signaling and drug action
10.1124/pr.111.005603 · 2013
Non-canonical G protein signaling
10.1016/j.pharmthera.2024.108589 · 2024
Non-canonical signaling and localizations of heterotrimeric G proteins
10.1016/j.cellsig.2011.08.014 · 2012
G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms
10.1097/fjc.0000000000000482 · 2017
β-Arrestin-mediated receptor trafficking and signal transduction
10.1016/j.tips.2011.05.002 · 2011
The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors
10.1074/jbc.r115.713313 · 2016
GPCR drug discovery: new agents, targets and indications
10.1038/s41573-025-01139-y · 2025
What Is the Role of β-Adrenergic Signaling in Heart Failure?
10.1161/01.res.0000102042.83024.ca · 2003
Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells
10.3390/ijms23158507 · 2022
Aberrant α-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells
10.1016/j.stemcr.2014.09.002 · 2014
Cardiac α1A-adrenergic receptors: emerging protective roles in cardiovascular diseases
10.1152/ajpheart.00621.2020 · 2021
AT1 receptor signaling pathways in the cardiovascular system
10.1016/j.phrs.2017.05.008 · 2017
β-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress
10.1126/scisignal.2000769 · 2010
AT2 receptor activities and pathophysiological implications
10.1097/fjc.0000000000000208 · 2015
Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling
10.1161/hypertensionaha.120.11941 · 2021
Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart
10.1007/s003950170003 · 2001
Muscarinic Receptors in Cardioprotection and Vascular Tone Regulation
10.33549/physiolres.935270 · 2024
The βγ subunits of GTP-binding proteins activate the muscarinic K+ channel in heart
10.1038/325321a0 · 1987
Voltage-dependent modulation of N-type calcium channels by G-protein βγ subunits
10.1038/380255a0 · 1996
Adrenergic and muscarinic receptors in the human heart
10.1016/s0031-6997(24)01425-x · 1999
Distribution and function of the muscarinic receptor subtypes in the cardiovascular system
10.1152/physiolgenomics.00062.2017 · 2018
Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans
10.1161/01.cir.88.1.43 · 1993
The role of endothelin and its receptors in cardiomyopathy: From molecular mechanisms to therapeutic insights
10.1016/j.prp.2025.155932 · 2025
Endothelin signalling regulates volume-sensitive Cl− current via NADPH oxidase and mitochondrial reactive oxygen species
10.1093/cvr/cvq125 · 2010
Cardiotoxic and Cardioprotective Features of Chronic β-Adrenergic Signaling
10.1161/circresaha.112.273896 · 2013
Chronic β2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism
10.1016/s0008-6363(02)00729-0 · 2003
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
10.1056/nejm198207223070401 · 1982
Adenylyl cyclase and G protein receptor kinase expression during development of heart failure
1997
Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart
10.1161/01.res.74.2.206 · 1994
Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart
10.1161/01.cir.87.2.454 · 1993
β-adrenoceptors in cardiac disease
10.1016/0163-7258(93)90030-h · 1993
Increase in myocardial Gi-proteins in heart failure
10.1016/s0140-6736(88)92601-3 · 1988
Clinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs
10.1111/cts.12674 · doi-reference
Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy
10.1126/scitranslmed.aax9276 · doi-reference
Why 90% of clinical drug development fails and how to improve it?
10.1016/j.apsb.2022.02.002 · doi-reference
Vascularized hiPSC-derived 3D cardiac microtissue on chip
10.1016/j.stemcr.2023.06.001 · doi-reference
Human heart organoids: current applications and future perspectives
10.1093/eurheartj/ehad841 · doi-reference
Substrate Stiffness Influences Structural and Functional Remodeling in Induced Pluripotent Stem Cell-Derived Cardiomyocytes
10.3389/fphys.2021.710619 · doi-reference
Physiological calcium combined with electrical pacing accelerates maturation of human engineered heart tissue
10.1016/j.stemcr.2022.07.006 · doi-reference
Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes
10.1016/j.celrep.2020.107925 · doi-reference
Age-Dependent Maturation of iPSC-CMs Leads to the Enhanced Compartmentation of β2AR-cAMP Signalling
10.3390/cells9102275 · doi-reference
Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation
10.1096/fj.15-280982 · doi-reference
Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells
10.1089/scd.2012.0490 · doi-reference
Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture
10.1253/circj.cj-12-0987 · doi-reference
Genome-wide pan-GPCR cell libraries accelerate drug discovery
10.1016/j.apsb.2024.06.023 · doi-reference
Vascular cells improve functionality of human cardiac organoids
10.1016/j.celrep.2023.112322 · doi-reference
Modeling heart failure by induced pluripotent stem cell-derived organoids
10.1016/j.bbadis.2025.167861 · doi-reference
Robust generation of human-chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases
10.1186/s13287-022-03215-1 · doi-reference
RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model
10.1371/journal.pone.0108051 · doi-reference
Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice
10.1161/01.res.0000172556.05576.4c · doi-reference
Contractile and Arrhythmic Effects of Endothelin Receptor Agonists in Human Heart In Vitro: Blockade with SB 2096701
10.1016/s0022-3565(24)35311-x · doi-reference
Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion
10.1161/01.cir.94.7.1752 · doi-reference
Endothelin has potent direct inotropic and chronotropic effects in cultured heart cells
10.1097/00004872-198900076-00044 · doi-reference
Endothelin-1 and angiotensin II modulate rate and contraction amplitude in a subpopulation of mouse embryonic stem cell-derived cardiomyocyte-containing bodies
10.1016/j.scr.2010.09.001 · doi-reference
A soft and ultrasensitive force sensing diaphragm for probing cardiac organoids instantaneously and wirelessly
10.1038/s41467-022-34860-y · doi-reference
Impact of Neurons on Patient-Derived Cardiomyocytes Using Organ-On-A-Chip and iPSC Biotechnologies
10.3390/cells11233764 · doi-reference
Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes
10.1038/s41467-019-13868-x · doi-reference
Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology
10.15252/emmm.201404757 · doi-reference
Atrial-like Engineered Heart Tissue: An In Vitro Model of the Human Atrium
10.1016/j.stemcr.2018.10.008 · doi-reference
Does Enhanced Structural Maturity of hiPSC-Cardiomyocytes Better for the Detection of Drug-Induced Cardiotoxicity?
10.3390/biom13040676 · doi-reference
Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior
10.1161/circulationaha.111.045146 · doi-reference
The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM)
10.1016/j.toxlet.2019.03.003 · doi-reference
iPSC-derived cardiac organoids for drug cardiotoxicity evaluation and efficacy prediction in myocardial infarction and cardiac hypertrophy models
10.1186/s13287-026-05079-1 · doi-reference
Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications
10.1038/s41467-024-46928-y · doi-reference
Human cardiac fibrosis-on-a-chip model recapitulates disease hallmarks and can serve as a platform for drug testing
10.1016/j.biomaterials.2019.119741 · doi-reference
Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells
10.1016/j.stemcr.2021.08.018 · doi-reference
Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy
10.1038/s41586-019-1406-x · doi-reference
Olmesartan Restores LMNA Function in Haploinsufficient Cardiomyocytes
10.1161/circulationaha.121.058621 · doi-reference
Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
10.3389/fphar.2023.1229960 · doi-reference
Maturation of human cardiac organoids enables complex disease modeling and drug discovery
10.1038/s44161-025-00669-3 · doi-reference
Self-assembled chamber-like cardiac organoids for modeling cardiac chamber formation and cardiotoxicity assessment
10.1038/s41467-026-73822-6 · doi-reference
PIV-MyoMonitor: an accessible particle image velocimetry-based software tool for advanced contractility assessment of cardiac organoids
10.3389/fbioe.2024.1367141 · doi-reference